News
Russia's EnteroMix vaccine, based on mRNA tech, showed 100% efficacy in early cancer trials. Designed to shrink tumours and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback